Lack of association between ABCC2 gene variants and treatment response in epilepsy

Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy

(2011) Mike Ufer et al.   Pharmacogenetics and Genomics

Gene-wide tagging study of the association betweenABCC2,ABCC5andABCG2genetic polymorphisms and multidrug resistance in epilepsy

(2011) Patrick Kwan et al.   PHARMACOGENOMICS

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function

(2010) S Laechelt et al.   PHARMACOGENOMICS JOURNAL

Rare Variants Create Synthetic Genome-Wide Associations

(2010) Samuel P. Dickson et al.   PLOS BIOLOGY

ABC Transporters in Drug-Refractory Epilepsy: Limited Clinical Significance of Pharmacogenetics?

(2009) I Cascorbi   CLINICAL PHARMACOLOGY & THERAPEUTICS

Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

(2009) Patrick Kwan et al.   EPILEPSIA

Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy

(2009) Dong Wook Kim et al.   EPILEPSY RESEARCH

The 5'-Untranslated Region of Multidrug Resistance Associated Protein 2 (MRP2; ABCC2) Regulates Downstream Open Reading Frame Expression through Translational Regulation

(2009) Y. Zhang et al.   MOLECULAR PHARMACOLOGY

Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 −24C>T polymorphism in young and adult patients with epilepsy

(2009) Mike Ufer et al.   Pharmacogenetics and Genomics

Genetic Structure of Europeans: A View from the North–East

(2009) Mari Nelis et al.   PLoS One

The clinical impact of pharmacogenetics on the treatment of epilepsy

(2008) Wolfgang Löscher et al.   EPILEPSIA

ABCC2haplotype is not associated with drug-resistant epilepsy

(2008) Takayuki Seo et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY